Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Selley

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Journal of Neurochemistry|April 2, 1998
Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptorsL J Sim, Q Liu, S R Childers, et al.
Brain Research|July 18, 1994
D2 inhibition of stimulated Fos immunoreactivity in cultured tyrosine hydroxylase-ir hypothalamic neuronsL J Sim, D E Selley, K P Tsai, et al.
European Journal of Pharmacology|June 20, 1996
Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatumL J Sim, D E Selley, R Xiao, et al.
Brain Research|August 8, 1994
Calcium and cAMP mediated stimulation of Fos in cultured hypothalamic tyrosine hydroxylase-immunoreactive neuronsL J Sim, D E Selley, K P Tsai, et al.
Life Sciences|January 1, 1996
Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranesD E Selley, S Stark, L J Sim, et al.
British Journal of Pharmacology|July 6, 2000
Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamusD E Selley, C C Cao, Q Liu, et al.
European Journal of Pharmacology|March 14, 2018
In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulatorSamuel Obeng, Yunyun Yuan, Abdulmajeed Jali, et al.
Brain Research|June 19, 1998
mu-Opioid agonist-stimulated [35S]GTPgammaS binding in guinea pig hypothalamus: effects of estrogenM J Cunningham, Y Fang, D E Selley, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2013
Structure activity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) analogues as potent opioid receptor ligands: preliminary results on the role of electronic characteristics for affinity and functionYunyun Yuan, Orgil Elbegdorj, Irina O Beletskaya, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2013
Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivativesYan Zhang, Orgil Elbegdorj, Yunyun Yuan, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Journal of Neurochemistry|April 2, 1998
Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptorsL J Sim, Q Liu, S R Childers, et al.
Brain Research|July 18, 1994
D2 inhibition of stimulated Fos immunoreactivity in cultured tyrosine hydroxylase-ir hypothalamic neuronsL J Sim, D E Selley, K P Tsai, et al.
European Journal of Pharmacology|June 20, 1996
Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatumL J Sim, D E Selley, R Xiao, et al.
Brain Research|August 8, 1994
Calcium and cAMP mediated stimulation of Fos in cultured hypothalamic tyrosine hydroxylase-immunoreactive neuronsL J Sim, D E Selley, K P Tsai, et al.
Life Sciences|January 1, 1996
Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranesD E Selley, S Stark, L J Sim, et al.
British Journal of Pharmacology|July 6, 2000
Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamusD E Selley, C C Cao, Q Liu, et al.
European Journal of Pharmacology|March 14, 2018
In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulatorSamuel Obeng, Yunyun Yuan, Abdulmajeed Jali, et al.
Brain Research|June 19, 1998
mu-Opioid agonist-stimulated [35S]GTPgammaS binding in guinea pig hypothalamus: effects of estrogenM J Cunningham, Y Fang, D E Selley, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2013
Structure activity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) analogues as potent opioid receptor ligands: preliminary results on the role of electronic characteristics for affinity and functionYunyun Yuan, Orgil Elbegdorj, Irina O Beletskaya, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2013
Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivativesYan Zhang, Orgil Elbegdorj, Yunyun Yuan, et al.
Pageof 15